|
|
|
|
|
|
|
Journal issues
|
The Hematology Journal
Editor: Professor Laurent Degos, Paris, France
Editorial policy The Hematology Journal is published six times a year. There are no page charges for submission or publication. The Hematology Journal accepts original articles, editorials and other contributions for the sections on Hematology in Focus, Hypothesis and Debate, Tools, Libraries and Procedures, and Open Forum. News items and Letters to the Editor may also be submitted for consideration. Areas of specific interest include:
Hypothesis and debate Hematology in Focus Tools, libraries and procedures Acceptance of material is based on scientific rigor and innovation. All material is subject to review by members of the Editorial Board and a panel of international reviewers. Copyright Authors must assign the world copyright of their manuscript to the European Haematology Association. All submitted manuscripts must be accompanied by a statement signed by all authors that the article is original, is not under consideration or has not been previously published elsewhere and its content has not been anticipated by any previous publication. Authors will be entitled to publish any part of their paper elsewhere, provided the usual acknowledgements are given. The assignment of copyright will not affect subsisting patent rights or arrangements relating to them. Submission of a manuscript will be taken to imply that authors have obtained permission from their employers or institution to publish, if they have a contractual or moral obligation to do so. Any material published in The Hematology Journal reflects the opinions of the authors only and not those of the Editors or the Publisher. Submission of manuscripts All material for publication should be sent to: The Hematology Journal Managing Editor: Andrea Bullock Preparation of manuscripts Manuscripts should be typed double-spaced on one side of 8 ½” x 11″ (A4) paper. They should be written in English and kept concise. An original and three copies (including figures) should be submitted to the editorial office. Any special points should be emphasised in the covering letter from the submitting author. Papers should be structured as follows: (a) Title page, (b) Structured Abstract, (c) Text, (d) References, (e) Figure and Table legends, (f) Figures and (g) Tables. Title page. List the title, full names of all authors, the corresponding author’s name, full postal address, telephone, fax and email, suggestions for a short running title, three to six keywords and acknowledgements of research support (if applicable). Structured Abstract. Include, on a separate page, no more than 250 words that adequately describe the work and highlight its significance. The abstract should be structured under the following headings: Introduction, Material and methods, Results and Conclusion. The abstract should include only text. Avoid the use of abbreviations and citations. Text. Use the standard format (Introduction, Materials and methods, Results, Discussion and Conclusion). Where appropriate, results and discussion may be combined. A section on Acknowledgements is necessary only when personal communications have been cited in the text. Abbreviations and contractions should be defined in the text when first used. References. Only papers closely related to the authors’ work should be cited. Exhaustive lists should be avoided. References should be numbered according to their first appearance in the text. At the end of the paper they should be listed (double-spaced) in numerical order corresponding to the order of citation in the text. All authors should be quoted. Titles of periodicals should be written out in full. Provide only the first page number for each reference. Abstracts and letters must be identified as such. Papers that are in press may be cited as much in the text, with “(in press)” replacing the publication date in the list of references. Papers submitted for publication, and work that has not yet been submitted, must be cited in the text as personal communication (including the full names and affiliation). Written permission from the person concerned must be provided when submitting your manuscript. Chapters within books should include all authors’ names and initials, chapter title, first page, name and initials of editor(s), book title, volume, edition, name and location of publisher and year of publication. Examples of References 2 Bullock AE, Monod TH. Myologie céphalique de deux espéces de poissons perroquets (Teleostei : Scaridae). Cybium 111: 276, 1997 3 Guegan J-F, Lek S, Oberdorff T. Energy availability in habitat heterogeneity predicts global riverine fish diversity. Nature 391: 382, 1998 4 Smith J, Doe J, Thistleworth G. The life and work of Rothko. Go Figure Publishing Co., Toronto, p185 (in press) 5. Greenberger JS. Long-term hematopoietic cultures, p 203 In: Golde DW (ed.) Hematopoiesis. Churchill-Livingstone, New York, 1984. Figures. Each figure should be arranged in numerical order with Arabic numerals and include an appropriate title and detailed legend defining any acronyms, abbreviations or symbols used. Each figure should be referred to in the text of the paper. Figure titles and legends must be listed on a separate sheet. All illustrations, including photographs, line drawings, halftones, photomicrographs or graphs, should be submitted as unmounted, glossy prints about 1.5 times final size. Submit four sets of figures: one set of figures created at the highest resolution possible and three sets suitable for reviewers. Indicate the figure number, first author, short manuscript title, and an arrow indicating the top, lightly in pencil on the back of each illustration. Please supply a scale bar and details of staining methods and magnification for photomicrographs. Colour photographs can be reproduced at extra cost to the author. Tables. Each table should be numbered consecutively with Arabic numerals and should have a separate caption or title. Methods not described in the text and abbreviations should be explained at the foot of the table. Each table should be referred to in the text of the paper. Avoid using vertical rules in tables. Use horizontal rules above and below the column headings and at the bottom of the table only. Special instructions Treatment trials. Studies involving human subjects must include details of age, origin, and sex of the person. All papers reporting results of investigations in patients and volunteer subjects must indicate that acceptable measures have been taken to obtain informed consent. Investigations in patients and healthy volunteers must indicate that informed consent was properly obtained and that the work was approved by the relevant Research Ethics Committee. In all material, patients must be identified by number or serial letter and not by initials or names. Where photographs of patients are to be published, the faces must be masked and authors must obtain written consent from patients for the use of these photographs. Manuscripts involving treatment trials authors must include: in the Materials and Methods section: A description of the planned study population together with the criteria used for inclusion and/or exclusion. Specific information must include planned interventions and their timing; primary and secondary outcome measures with the minimum important differences and an indication of how the target sample size was projected. The rationale and methods for statistical analyses are also required with information detailing the main comparative analyses and whether they were completed on an intention-to-treat basis. Indicate prospectively defined stopping rules where they are warranted. in the Results section: a trial profile in the form of an illustration summarising participant flow, numbers and timing of randomisation assignment, interventions and measurements for each group. In describing the results of their analyses, authors must state the estimated effect of intervention on primary and secondary outcome measures, using absolute numbers (and not percentages) when feasible. Drug dosages. All drugs must be referred to by their generic names at their first appearance in the text. Unfamiliar compounds other than drugs must also be designated, at first reference, by their correct systemic names. Systematic chemical names should conform to the usage given in the indexes of Chemical Abstracts. Drug dosages must be clearly indicated. Avoid using non-standard abbreviations. Consider including the total dose or the total number of doses in parentheses. While published information is the responsibility of the author, ultimate responsibility for ensuring that drug dosages are correctly prescribed lies with the clinician. Reagents. Information concerning the origin of all manufactured reagents must be provided by the authors. It is understood that by publishing a paper in The Hematology Journal authors agree to make freely available to colleagues in academic research any of the reagents, cell lines, antibodies and DNA clones etc that were used in the research reported and that are not available from commercial suppliers. GenBank. Authors reporting original DNA sequences in The Hematology Journal must also submit their sequences to GenBank. Accession numbers attributed by GenBank should be indicated in published articles. Recombinant DNA. Authors using “recombinant” material in research, particularly recombinant viral vectors that may infect human cells, must include a statement regarding the containment category of genetically engineered organisms and indicate clearly the procedures and safeguards required for the construction and handling of recombinant DNA molecules and organisms or viruses containing recombinant DNA. Submission on disk Once accepted for publication the final version of the manuscript may be submitted on disk provided it meets the following criteria:
Please refer to Publishers for instructions on electronic submission of artwork. Permissions Authors must obtain permission to reproduce all maps, diagrams, figures and photographs. As a rule it is also necessary to obtain permission for single passages of prose exceeding 250 words, or scattered passages totalling more than 400 words from any one work. Please supply the publisher with full information for all work cited, including author, date published, publisher and page references. Copyright extends to 50 years after the death of the author or 50 years after publication of a scholarly edition, whichever is longer. Proofs. Contributors are provided with page proofs to read for typesetting errors. Important changes in data are allowed, but authors may be charged for excessive alterations in proofs. Proofs must be returned to the publishers within 48 hours of receipt. If proofs are not returned within this time period, the Editor will have the right to publish any article without the alterations. Offprints. An offprint order form is sent with proofs; 25 free offprints are supplied to the principal author. Additional offprints may be ordered. Charges for reprints ordered at a later date are necessarily higher. Business matters. Business correspondence and enquiries relating to advertising, subscriptions, back numbers or reprints should be addressed to the Publishers at Nature Publishing Group, Houndmills, Basingstoke, Hampshire RG21 6XS, UK.
Last Updated 21 March 2001 |
